Croma-Pharma Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast
Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, announced the acquisition of Novaestiq Corp. by Waldencast plc. Novaestiq, a joint venture between Croma-Pharma and Gore Range Capital, is the company behind the innovative Saypha ChIQ and Saypha MagIQ injectable hyaluronic acid gels, which a…
